Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
|
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19.01.23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01.11.18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02.03.22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08.02.22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01.11.18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26.04.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13.04.18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11.12.15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31.10.17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20.04.20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20.04.20 |
Julia Haller
BRD | Director/Board Member | 69 | 11.08.22 |
Director/Board Member | 39 | 11.09.17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19.06.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 23 405 637 | 14 743 307 ( 62,99 %) | 0 | 62,99 % |
Unternehmenskontakt
Outlook Therapeutics, Inc.
111 South Wood Avenue Unit 100
08830, Iselin
+609 619 3990
http://www.outlooktherapeutics.com![Straße Oncobiologics Inc](https://cdn.zonebourse.com/static/address/27548026.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+21,85 % | 46,93 Mrd. | |
+37,63 % | 39,08 Mrd. | |
-8,05 % | 38,48 Mrd. | |
+29,04 % | 31,01 Mrd. | |
-13,75 % | 26,14 Mrd. | |
+10,65 % | 25,88 Mrd. | |
+38,43 % | 12,53 Mrd. | |
-6,92 % | 11,36 Mrd. | |
-12,29 % | 10,65 Mrd. |
- Börse
- Aktien
- A4046T Aktie
- Aktie
- Unternehmen Oncobiologics Inc